Bushra Sayed News Today

The rates are discriminatory and arbitrary, says the petition

Updated: Share Article AAA The Bombay High Court on Thursday refused to hear a public interest litigation (PIL) petition seeking to quash the different rates of COVID-19 vaccines by Serum Institute of India (SII) and Bharat Biotech for the Centre and State governments and fix the price at ₹150 per dose. A Division Bench of Chief Justice Dipankar Datta and Justice G.S. Kulkarni said, “The Supreme Court has said that issues that have pan-India effect will be dealt with by it and pricing is a...

MUMBAI: Let there be uniform Covid-19 vaccine rates, a public interest litigation has urged the Bombay High Court challenging the intelligible different rates of Covishield and Covaxin by pharmaceutical companies for sale to government and private hospitals. The PIL is filed by advocate Fayzan Khan and three law students - Arman Parve, Bushra Sayed and Trupti Gaikar - who are aggrieved at the varying charges announced by Serum Institute of India for its vaccine Covidshield at Rs 400/- for Stat...